These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39041572)

  • 1. [Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis].
    Li Z; Luo C; Wu L; Wu X; Meng X; Chen X; Shi Y; Zhong Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Aug; 56(4):729-734. PubMed ID: 39041572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of anti-carbamylated protein antibody in patients with rheumatoid arthritis: association with disease activity and bone destruction.
    Zhang B; Lei Y; Li X; Gao Z; Xia L; Lu J; Shen H
    J Investig Med; 2020 Aug; 68(6):1186-1192. PubMed ID: 32690598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease].
    Zhu H; Zhao LJ; Zhou Y; Chen Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1003-1007. PubMed ID: 31848494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Carbamylated Protein Antibodies in ACPA-Negative and ACPA-Positive Patients with Rheumatoid Arthritis.
    Dibrov DA; Avdeeva AS; Diatroptov ME; Nasonov EL
    Dokl Biochem Biophys; 2024 Aug; 517(1):235-242. PubMed ID: 39002007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of anti-Sa antibody and anti-carbamylated protein antibody for rheumatoid arthritis].
    Lyu YK; Li ZA; A XR; Ma JD; Zhou JW; Wang LJ
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2947-2951. PubMed ID: 37752054
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
    Elsayed SA; Esmail MA; Ali RM; Mohafez OM
    Clin Rheumatol; 2019 Oct; 38(10):2683-2689. PubMed ID: 31161487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-carbamylated Protein Antibodies Positivity in Rheumatoid Arthritis and Its Association With Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibodies.
    Balaji D; Mohanasundaram K; Gopalakrishnan KV; Suthakaran PK
    Cureus; 2024 Jul; 16(7):e63652. PubMed ID: 39092366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment and application of quantitative detection of serum anti-carbamylated protein autoantibodies by microarray chemiluminescence immunoassay].
    Yao X; Xue M; Gui T; Ma C; Jiang X; Yan H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):924-930. PubMed ID: 30554586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
    Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
    Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
    Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of 14-3-3η and anti-carbamylated protein antibodies in Rheumatoid Arthritis in Han population of Northern China.
    Zhang Y; Liang Y; Feng L; Cui L
    Clin Chim Acta; 2020 Mar; 502():102-110. PubMed ID: 31862264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of glucose-6-phosphate isomerase assay in early diagnosis of rheumatoid arthritis].
    Xu J; Liu J; Zhu L; Zhang XW; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):942-946. PubMed ID: 27987494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
    Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
    Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.
    Heidari B; Firouzjahi A; Heidari P; Hajian K
    Ann Saudi Med; 2009; 29(6):467-70. PubMed ID: 19847085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
    Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
    Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum anti-carbamylated protein antibodies with disease activity and bone loss in rheumatoid arthritis.
    Wang L; Hua L; Hong X; Chen F; Du H
    Clin Chim Acta; 2023 Jun; 546():117371. PubMed ID: 37127229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.
    Regueiro C; Rodriguez-Rodriguez L; Triguero-Martinez A; Nuño L; Castaño-Nuñez AL; Villalva A; Perez-Pampin E; Lopez-Golan Y; Abasolo L; Ortiz AM; Herranz E; Pascual-Salcedo D; Martínez-Feito A; Boveda MD; Gomez-Reino JJ; Martín J; Gonzalez-Escribano MF; Fernandez-Gutierrez B; Balsa A; Gonzalez-Alvaro I; Gonzalez A
    Arthritis Rheumatol; 2019 Mar; 71(3):331-339. PubMed ID: 30277011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-carbamylated protein antibodies in premenopausal rheumatoid arthritis women: relation to disease activity and bone loss.
    Elsawy NA; Mohamed RA; Ghazala RA; Abdelshafy MA; Elnemr R
    Rheumatology (Oxford); 2021 Mar; 60(3):1419-1428. PubMed ID: 32995835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
    Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
    Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.